Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1700067	重组人γ-干扰素腺病毒注射液	Injection	Biological Products(3)	New Drug Application	2017-09-05	广州达博生物制品有限公司	Doublle Bioproduct IncGuangzhou PRC	Certificate Issued	2018-05-30	view
X0300833	重组人内皮抑素腺病毒注射液	Injection	Biological Products(1)	New Drug Application	2004-09-21	广州达博生物制品有限公司	Doublle Bioproduct IncGuangzhou PRC	Certificate Issued	2004-12-24	view
CXSB1100019	重组人内皮抑素腺病毒注射液	Injection	Biological Products	Supplementary Application	2012-02-03	广州达博生物制品有限公司	Doublle Bioproduct IncGuangzhou PRC	Certificate Issued	2012-12-25	view
CXSL0600043	重组人γ-干扰素腺病毒注射液	Injection	Biological Products(1)	New Drug Application	2006-08-20	广州达博生物制品有限公司	Doublle Bioproduct IncGuangzhou PRC	Certificate Issued	2012-10-30	view
CXSL2100067	重组人γ-干扰素腺病毒注射液	Injection	Biological Products(1)	New Drug Application	2021-02-24	广州达博生物制品有限公司	Doublle Bioproduct IncGuangzhou PRC	In Review	2021-02-23	view
CXSB0600050	重组人内皮抑素腺病毒注射液	Injection	Biological Products	Supplementary Application	2006-06-23	广州达博生物制品有限公司	Doublle Bioproduct IncGuangzhou PRC	Certificate Issued	2007-06-11	view